Vital Signs - From Being Afraid to Miss Out to Afraid to Invest: How the dynamics of venture capital funding are changing in the medical technologies space

 

USD 1,500

* Required Fields

USD 1,500

PAY BY INVOICE

Be the first to review this product

This issue of Vital Signs, released on August 11, 2010, provides a strategic analysis of changing dynamics of venture capital funding in the medical technologies space. Additionally, a company spotlight is provided for ZONARE Medical Systems, a company focused on design, development, and manufacturing of high-performance ultrasound solutions, which combine revolutionary technology with an innovative physical design. Reimbursement and regulatory news from the FDA is also provided for the week of July 19, 2010.

Table of Contents

Vital Signs - From Being ‘Afraid to Miss Out’ to ‘Afraid to Invest’: How the dynamics of venture capital funding are changing in the medical technologies spaceVital Signs: 11 August 2010This week's issue:




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 20-Nov-17

Region : North America

Release Date : 07-Nov-17

Region : North America

Release Date : 06-Nov-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.